Document ID: chunk:federal_register_of_legislation:F2020L00494:reg:9:p2
Version: federal_register_of_legislation:F2020L00494
Segment Type: reg
Provision Reference: reg 9 (pt 2/2)
Character Range: 7046–8454

week, for at least the four weeks before the clinical worsening of patellar tendinopathy;
Note: MET is defined in the Schedule 1 - Dictionary.
(12)      increasing the frequency, duration or intensity of weight bearing activity involving the affected knee by at least 100 percent, to a minimum intensity of five METs for at least two hours per day, within the seven days before the clinical worsening of patellar tendinopathy;
Note: MET is defined in the Schedule 1 - Dictionary.
(13)      having direct trauma to the patellar tendon of the affected knee at the time of the clinical worsening of patellar tendinopathy;
(14)      having gout of the patellar tendon or distal quadriceps tendon at the time of the clinical worsening of patellar tendinopathy;
(15)      being treated with a glucocorticoid drug as specified before the clinical worsening of patellar tendinopathy;
            Note: being treated with a glucocorticoid drug as specified is defined in the Schedule 1 - Dictionary.
(16)      being treated with a fluoroquinolone antibiotic within the 60 days before the clinical worsening of patellar tendinopathy;
(17)      for distal quadriceps tendinopathy or rupture only, being treated with atorvastatin for at least three months within the one year before the clinical worsening of patellar tendinopathy;
(18)      inability to obtain appropriate clinical management for patellar tendinopathy.